Compare CAPR & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAPR | HNST |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 585.8M |
| IPO Year | 2011 | 2021 |
| Metric | CAPR | HNST |
|---|---|---|
| Price | $9.37 | $5.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $44.63 | $3.05 |
| AVG Volume (30 Days) | ★ 9.1M | 3.4M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $371,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.31 | $5.93 |
| P/E Ratio | ★ N/A | $65.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.96 | $2.07 |
| 52 Week High | $40.37 | $5.96 |
| Indicator | CAPR | HNST |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 72.78 |
| Support Level | $3.66 | $3.22 |
| Resistance Level | $30.39 | N/A |
| Average True Range (ATR) | 1.21 | 0.27 |
| MACD | 0.87 | 0.02 |
| Stochastic Oscillator | 68.14 | 93.23 |
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.